Koschinsky ML - Search Results

1

Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells.

Boffa MB, Hamill JD, Maret D, Brown D, Scott ML, Nesheim ME, Koschinsky ML. Boffa MB, et al. Among authors: koschinsky ml. J Biol Chem. 2003 Mar 14;278(11):9250-7. doi: 10.1074/jbc.m209588200. J Biol Chem. 2003. PMID: 12645517 Free article.

2

Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation.

Sangrar W, Bajzar L, Nesheim ME, Koschinsky ML. Sangrar W, et al. Among authors: koschinsky ml. Biochemistry. 1995 Apr 18;34(15):5151-7. doi: 10.1021/bi00015a028. Biochemistry. 1995. PMID: 7711034

3

Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.

Koschinsky ML, Côté GP, Gabel B, van der Hoek YY. Koschinsky ML, et al. J Biol Chem. 1993 Sep 15;268(26):19819-25. J Biol Chem. 1993. PMID: 8366120 Free article.

4

The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.

Sangrar W, Gabel BR, Boffa MB, Walker JB, Hancock MA, Marcovina SM, Horrevoets AJ, Nesheim ME, Koschinsky ML. Sangrar W, et al. Among authors: koschinsky ml. Biochemistry. 1997 Aug 26;36(34):10353-63. doi: 10.1021/bi962433d. Biochemistry. 1997. PMID: 9265615

5

Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B).

Boffa MB, Reid TS, Joo E, Nesheim ME, Koschinsky ML. Boffa MB, et al. Among authors: koschinsky ml. Biochemistry. 1999 May 18;38(20):6547-58. doi: 10.1021/bi990229v. Biochemistry. 1999. PMID: 10350473

6

Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a).

Becker L, McLeod RS, Marcovina SM, Yao Z, Koschinsky ML. Becker L, et al. Among authors: koschinsky ml. J Biol Chem. 2001 Sep 28;276(39):36155-62. doi: 10.1074/jbc.M104789200. Epub 2001 Jul 25. J Biol Chem. 2001. PMID: 11473115 Free article.

7

A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels.

Brouwers GJ, Vos HL, Leebeek FW, Bulk S, Schneider M, Boffa M, Koschinsky M, van Tilburg NH, Nesheim ME, Bertina RM, Gómez Garcia EB. Brouwers GJ, et al. Blood. 2001 Sep 15;98(6):1992-3. doi: 10.1182/blood.v98.6.1992. Blood. 2001. PMID: 11565542 Free article. No abstract available.

8

Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.

Schneider M, Boffa M, Stewart R, Rahman M, Koschinsky M, Nesheim M. Schneider M, et al. J Biol Chem. 2002 Jan 11;277(2):1021-30. doi: 10.1074/jbc.M104444200. Epub 2001 Oct 29. J Biol Chem. 2002. PMID: 11684677 Free article.

9

Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAF1) with blood pressure.

Koschinsky ML, Boffa MB, Nesheim ME, Zinman B, Hanley AJ, Harris SB, Cao H, Hegele RA. Koschinsky ML, et al. Clin Genet. 2001 Nov;60(5):345-9. doi: 10.1034/j.1399-0004.2001.600504.x. Clin Genet. 2001. PMID: 11903334

10

A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitor.

Boffa MB, Hamill JD, Bastajian N, Dillon R, Nesheim ME, Koschinsky ML. Boffa MB, et al. Among authors: koschinsky ml. J Biol Chem. 2002 Jul 12;277(28):25329-36. doi: 10.1074/jbc.M203688200. Epub 2002 May 8. J Biol Chem. 2002. PMID: 12000765 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page